Weight-loss drugs didn't curb health costs within two years

Weight-loss drugs didn't curb health costs within two years

Source: 
Reuters
snippet: 
  • Costs rose 46% over two years for patients trying GLP-1 drugs for obesity
  • Obesity treatment did not reduce other medical costs, data show
  • Only one in four patients were still on Wegovy or Ozempic two years later